Índice

• • ·Editorial Board

    Página :i

    

• French Epilepsy Congress 2019

  • ·The future of epilepsy

    Página :407

    S. Dupont, V. Navarro

    Esquema Esquema
  • ·Etiological assessment of status epilepticus

    Página :408-426

    L. Valton, M. Benaiteau, M. Denuelle, F. Rulquin, C. Hachon Le Camus, C. Hein, A. Viguier, J. Curot

    Resumen Resumen Esquema Esquema   
  • ·Genetic/idiopathic generalized epilepsies: Not so good as that!

    Página :427-438

    A. Nilo, P. Gelisse, A. Crespel

    Resumen Resumen Esquema Esquema  
  • ·Getting older with chronic temporal lobe epilepsy: What memory profile?

    Página :439-443

    S. Samson, C. Moncomble, M. Méré, R. Vasseur, S. Dupont

    Resumen Resumen Esquema Esquema
  • ·Lennox-Gastaut syndrome: New treatments and treatments under investigation

    Página :444-447

    S. Auvin

    Resumen Resumen Esquema Esquema
  • ·Long-term cognitive outcomes in patient with epilepsy

    Página :448-455

    N. Forthoffer, H. Brissart, L. Tyvaert, L. Maillard

    Resumen Resumen Esquema Esquema
  • ·Depression could modulate neuropsychological status in epilepsy

    Página :456-467

    N. Forthoffer, C. Kleitz, M. Bilger, H. Brissart

    Resumen Resumen Esquema Esquema  
  • ·Social cognition in epilepsy: State of the art and perspectives

    Página :468-479

    H. Mirabel, V. Guinet, V. Voltzenlogel, S. Pradier, S. Hennion

    Resumen Resumen Esquema Esquema  
  • ·Wearable devices for seizure detection: Is it time to translate into our clinical practice?

    Página :480-484

    S. Rheims

    Resumen Resumen Esquema Esquema

• Controversies of the French MS Society

  • ·Should spinal cord MRI be systematically performed for diagnosis and follow-up of multiple sclerosis? No

    Página :485-486

    S. Kremer

    Esquema Esquema
  • ·Should spinal cord MRI be systematically performed for diagnosis and follow up of multiple sclerosis? Yes

    Página :487-489

    A. Kerbrat, G. Edan

    Esquema Esquema  
  • ·Should spinal cord MRI be systematically performed for diagnosis and follow-up of multiple sclerosis? Synthesis

    Página :490-493

    F. Durand-Dubief

    Esquema Esquema
  • ·Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? No

    Página :494-496

    P. Labauge

    Resumen Resumen Esquema Esquema
  • ·Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Yes

    Página :497-499

    J. de Seze, K. Bigaut

    Resumen Resumen Esquema Esquema
  • ·Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment

    Página :500-504

    J.-C. Ouallet

    Resumen Resumen Esquema Esquema  

• COVID-19

  • ·COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?

    Página :505-506

    M. Aubignat, O. Godefroy

    Esquema Esquema
  • ·Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

    Página :507-515

    G. Solé, E. Salort-Campana, Y. Pereon, T. Stojkovic, K. Wahbi, P. Cintas, D. Adams, P. Laforet, V. Tiffreau, I. Desguerre, L.I. Pisella, A. Molon, S. Attarian, FILNEMUS COVID-19 study group

    Resumen Resumen Esquema Esquema
  • ·COVID-19 may induce Guillain–Barré syndrome

    Página :516-518

    J.-P. Camdessanche, J. Morel, B. Pozzetto, S. Paul, Y. Tholance, E. Botelho-Nevers

    Esquema Esquema
  • ·Covid-19 and Guillain-Barré syndrome: More than a coincidence!

    Página :518-519

    H. El Otmani, B. El Moutawakil, M.-A. Rafai, N. El Benna, C. El Kettani, M. Soussi, N. El Mdaghri, H. Barrou, H. Afif

    Esquema Esquema  
  • ·Acute meningoencephalitis in a patient with COVID-19

    Página :519-521

    H. Chaumont, P. Etienne, E. Roze, C. Couratier, P.-M. Roger, A. Lannuzel

    Esquema Esquema  
  • ·First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case

    Página :521-523

    H. Hemasian, B. Ansari

    Esquema Esquema  
  • ·Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum

    Página :523-525

    C. Louapre, E. Maillart, T. Roux, V. Pourcher, G. Bussone, C. Lubetzki, C. Papeix

    Esquema Esquema  

• Erratum

  • ·Erratum to “What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature” [Rev. Neurol. 176 (4) (2019) 235–243]

    Página :526

    V. Pourcher

    Esquema Esquema